下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEChlorpromazineCat.No.:HY-12708CASNo.:50-53-3分?式:C??H??ClN?S分?量:318.86作?靶點(diǎn):DopamineReceptor;CytochromeP450;Autophagy作?通路:GPCR/GProtein;NeuronalSignaling;MetabolicEnzyme/Protease;Autophagy儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Chlorpromazine可?于抗精神病的研究,可?擾多個(gè)配體和電壓門控通道[1]。Chlorpromazine?種有效的多巴胺(dopamine)拮抗劑[2]。Chlorpromazine抑制CYP1A2和CYP2D6活性,IC50分別為9.5和20μM[3]。Chlorpromazine可誘導(dǎo)?噬(autophagy),但不誘導(dǎo)細(xì)胞凋亡[4]。體外研究TheeffectofChlorpromazineonGABAARbindingrate,resultinginsloweronsetofGABA-evokedcurrents,providesatooltoestimatethespeedofsynapticclearanceofGABA.Chlorpromazine,awidelyusedantipsychoticdrug,stronglyaffectstheGABA-mediatedinhibitorysynaptictransmissionbydecreasingtheamplitudeandbyacceleratingthedecayofmIPSCs.CPZdecreasestheamplitudeandacceleratesthedecayofmIPSCs[1].ChlorpromazineinhibitsCYP1A2andCYP2D6activitywithKisof4.75and10μM,respectively[3].Chlorpromazineisaphenothiazinederivativebelongingtothefirstgenerationofatypicalantipsychoticagent.Chlorpromazine(10-40μM)showsantitumoreffectsinU-87MGgliomacells.Chlorpromazinepromotesantitumoralactionthroughinductionofcelldeath[4].Chlorpromazine(20μM)causesinhibitionofcellcycleprogression[4].CellProliferationAssay[4]CellLine:U-87MGgliomacellsConcentration:0,10,20and40μMIncubationTime:0,24and48hours1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEResult:Adecreaseincellularproliferationwasobservedincellsinadose-andtime-dependentmannercomparedwithuntreatedcontrolcells.Asignificantdecreaseincellviabilitywasobservedincellstreatedfor24hwithhighconcentration(≥20μM)comparedwithuntreatedcontrolcells.WesternBlotAnalysis[4]CellLine:U-87MGcellsConcentration:20μMIncubationTime:0,12,24,48hoursResult:After12hexposure,thelevelsofcyclinAandcyclinB1decreased,whereaslevelsofcyclinD1,proliferatingcellnuclearantigenandGAPDHremainedunchanged.體內(nèi)研究Chlorpromazine(20mg/kg;injectedintraperitoneallydailyfor7days)inhibitsxenografttumorgrowthinnudemouse[4].AnimalModel:5-to6-week-oldathymicnudemicebearingintracranialU-87MGxenografttumors[4]Dosage:20mg/kgAdministration:Injectedintraperitoneallydailyfor7daysResult:Treatmentinhibitedxenografttumorgrowthonday24comparedwithcontroltreatment.Inhibitionoftumorgrowthbegantobeobservedafterday17;onday24,thetumorsizesignificantlydecreasedfrom690±112mm3inthecontrolgroupto390±81mm3inthetreatedgroup,accountingfora43.5%inhibitionintumorgrowth.戶使?本產(chǎn)品發(fā)表的科研?獻(xiàn)?AdvFunctMater.2020,2004940.?ACSNano.2020Nov24;14(11):14698-14714.?JAmChemSoc.2018Dec12;140(49):17234-17240.?Biomaterials.13January2022,121373.?Theranostics.2021May24;11(15):7308-7321.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].JWMozrzymas,etal.ChlorpromazineinhibitsminiatureGABAergiccurrentsbyreducingthebindingandbyincreasingtheunbinding2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemErateofGABAAreceptors.JNeurosci.1999Apr1;19(7):2474-88.[2].MWHarrold,etal.Chargedanaloguesofchlorpromazineasdopamineantagonists.JMedChem.1987Sep;30(9):1631-5.[3].GuillermoGervasini,etal.Comparativecytochromep450invitroinhibitionbyatypicalantipsychoticdrugs.ISRNPharmacol.2013;2013:792456.[4].SoonYoungShin,etal.TheantipsychoticagentchlorpromazineinducesautophagiccelldeathbyinhibitingtheAkt/mTORpathwayinhumanU-87MGgliomacells.Carcinogenesis.2013Sep;34(9):2080-9.McePdfHeightCaution
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 八年級(jí)上冊(cè)道德與法治知識(shí)點(diǎn)提升練習(xí)第1課時(shí) 網(wǎng)絡(luò)改變世界
- 2024年光纖用GECL4項(xiàng)目合作計(jì)劃書
- 裝修居間服務(wù)照明系統(tǒng)合同
- 藥品冷鏈運(yùn)輸服務(wù)合同
- 教育培訓(xùn)居間合作協(xié)議
- 游樂(lè)場(chǎng)門窗改造合同樣本
- 木材加工運(yùn)輸協(xié)議樣本
- 汽油批發(fā)液體運(yùn)輸協(xié)議
- 研發(fā)中心垃圾清運(yùn)服務(wù)合同
- 飼料原料運(yùn)輸合同樣板
- 2023年北師大版初三數(shù)學(xué)圓練習(xí)一知識(shí)點(diǎn)多選題易錯(cuò)題
- 北師大版三年級(jí)數(shù)學(xué)上冊(cè)-期中整理與復(fù)習(xí)課件
- 鹽堿地綜合治理試點(diǎn)項(xiàng)目施工組織設(shè)計(jì)方案
- 纖維支氣管鏡質(zhì)控
- 深靜脈血栓形成(DVT)風(fēng)險(xiǎn)因素評(píng)估表、上報(bào)表
- 2022-2023學(xué)年浙教新版七年級(jí)上冊(cè)數(shù)學(xué)期中復(fù)習(xí)試卷(有答案)
- 螺旋面及其加工原理
- 2022-2023上學(xué)期《中國(guó)特色社會(huì)主義》期中考試
- 市政工程規(guī)模劃分標(biāo)準(zhǔn)
- 宴席菜單設(shè)計(jì)-課件
- DLT5210.4-2018熱工施工質(zhì)量驗(yàn)收表格
評(píng)論
0/150
提交評(píng)論